Morgan Stanley Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $51
Morgan Stanley Maintains Overweight on Bath & Body Works, Lowers Price Target to $51
Morgan Stanley Maintains Bath & Body Works(BBWI.US) With Buy Rating, Cuts Target Price to $51
Crafting a Buy Rating: Insights From Alexandra Straton's Bath & Body Works Analysis
A Quick Look at Today's Ratings for Bath & Body Works(BBWI.US), With a Forecast Between $38 to $56
Bath & Body Works Price Target Cut to $42.00/Share From $53.00 by Telsey Advisory Group
A Quick Look at Today's Ratings for Bath & Body Works(BBWI.US), With a Forecast Between $35 to $56
Bath & Body Works Is Maintained at Buy by B of A Securities
Bath & Body Works Analyst Ratings
BMO Capital Adjusts Price Target on Bath & Body Works to $50 From $52, Maintains Outperform
Bath & Body Works: Hold Rating Maintained Amid Cost-Cutting and Uncertain Sales Rebound
Barclays Remains a Hold on Bath & Body Works (BBWI)
Bath & Body Works: A Resilient Model and Undervalued Stock Justify a Buy Rating
Bath & Body Works Is Maintained at In-Line by Evercore ISI Group
Evercore ISI Adjusts Bath & Body Works Price Target to $35 From $45
Bath & Body Works (BBWI) Receives a Buy From Telsey Advisory
Wells Fargo Maintains Bath & Body Works(BBWI.US) With Hold Rating, Maintains Target Price $40
Bath & Body Works Faces Strategic Challenges and Innovation Headwinds: Analyst Maintains Hold Rating
Bath & Body Works Price Target Cut to $54.00/Share From $57.00 by Deutsche Bank
Bath & Body Works Analyst Ratings